PR Newswire Asia's news > Biotechnology

< Previous page

All Airlines/Aviation Auto Maritime/Shipbuilding Transportation Computer Hardware Computer Networks Computer Software Computer/Electronics Electronic Commerce Electronic Components High Tech Security Internet Technology Peripherals Semiconductors Electronics Gaming Consumer Electronics Mobile Entertainment Multimedia/Online/Internet Telecommunications Household/Consumer/Cosmetics Retail Supermarkets Toys Alternative Energies Chemical Mining/Metals Oil/Energy Environmental Products & Services Green Technology Art Cosmetics & Personal Care Entertainment Fashion Film & Motion Picture Jewelry Banking/Financial Service Insurance Workforce Management/Human Resources Education Higher Education Biotechnology Health Care/Hospital Infectious Disease Control Medical Equipment Medical/Pharmaceuticals Agriculture Machinery Paper/Forest Products/Containers Textiles Domestic policy Legal issues Sports Hotels and Resorts Leisure/Travel/Hotels Travel Restaurants Beer, Wine & Spirits Beverages Non-Alcoholic Beverages Food/Beverages Advertising Books Music Publishing/Information Service Television Trade show news Real Estate Construction/Building Furniture & Furnishings  |   Title only   |   Print

Next page >

88IV - PR Newswire Asia's news - Biotechnology 5 Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer Appointments Reinforce Deep Technical Expertise in Biotech R&D and Capital Markets Leadership as Origin Advances Its Commercial Pipeline ... 2026-03-24T    Agriculture   Biotechnology  Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women's Health CAMBRIDGE, Mass. , March 24, 2026 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced ... 2026-03-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC CHENGDU, China , March 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that the Investigational ... 2026-03-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  DualityBio (9606.HK) Announces 2025 Annual Results HONG KONG , March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as "DualityBio" or the "Company"), a leading ... 2026-03-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab) Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced non-squamous non-small cell lung cancer ... 2026-03-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF Revenue amounted to approximately RMB2057.92 million, and gross profit amounted to approximately RMB1478.78 million, representing a year-on-year increase. R&D Expenses was approximately RMB1319.68 ... 2026-03-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS ... 2026-03-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Insilico Medicine Launches PandaClaw: Empowering Biologists with Agentic AI for Therapeutic Discovery CAMBRIDGE, Mass. , March 23, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the ... 2026-03-23T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals  Cambrex Advances US and European Expansions EAST RUTHERFORD, N.J. , March 23, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the completion of initial engineering studies ... 2026-03-23T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals  Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies MELBOURNE, Australia , March 23, 2026 /PRNewswire/ -- Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, today announced ... 2026-03-23T    Biotechnology   Education   Health Care/Hospital   Higher Education
< Previous page	Next page >